Clinical trialNo phase (not a drug trial)Terminated
Preoperative Prehabilitation for Sarcopenic Patients Prior to Pancreatic Surgery for Cancer
Prehabilitaion Program for Sarcopenic Patients Prior to Pancreaticoduodenectomy for Periampullary Malignant Tumors
- Outcome
- Stopped earlyThe study was terminated prematurely due to patient inclusion difficulties. (Enrollment)
- Phase
- No phase (not a drug trial)
- Status
- Terminated
- Study type
- Interventional
- Start
- 17 May 2022
- Ended
- 17 June 2025
- Enrollment
- 6 participants
- Sites
- 1
- Primary outcomes
- Post-operative severe pancreatic fistula (Grade B and C)
- Sponsor type
- Academic / other
- Results posted
- No
- Last update
- 14 July 2026
These fields come from the trial’s registry entry. A summary of its population, design, endpoints and results, each tied to a quote, has not been written for this trial yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
Brief summary public domain (ClinicalTrials.gov)
Major digestive surgery is associated with a significant rate of postoperative complications. To improve postoperative outcome, efforts are focused on postoperative course leading to the concept of rehabilitation. However, the rehabilitation concept does not allow to improve muscular and functional reserves at the time of surgery. Sarcopenia is a condition characterized by loss of skeletal muscle mass and function. Also, the prevalence of sarcopenia in patients with cancer is high and has a prevalence of around 25% in patients with pancreatic cancer, with a considerable impact on postoperative and survival outcomes. The hypothesis is the preoperative management of sarcopenia by a rehabilitation program could improve patients' operative outcomes by reducing the rate of postoperative complications.